4.6 Article

MicroRNAs of Epstein-Barr Virus Control Innate and Adaptive Antiviral Immunity

Journal

JOURNAL OF VIROLOGY
Volume 91, Issue 16, Pages -

Publisher

AMER SOC MICROBIOLOGY
DOI: 10.1128/JVI.01667-16

Keywords

cancer; human herpesviruses; immune evasion; immune surveillance; microRNA

Categories

Funding

  1. Deutsche Forschungsgemeinschaft [SFB1064/TP A13, SFB-TR36/TP A04]
  2. Deutsche Krebshilfe [107277, 109661]
  3. National Cancer Institute [CA70723]
  4. Deutscher Akademischer Austauschdienst (DAAD) (Studienstipendien fur auslandische Graduierte aller wissenschaftlichen Facher)

Ask authors/readers for more resources

Epstein-Barr virus (EBV) has established lifelong infection in more than 90% of humanity. While infection is usually controlled by the immune system, the human host fails to completely eliminate the pathogen. Several herpesviral proteins are known to act as immunoevasins, preventing or reducing recognition of EBV-infected cells. Only recently were microRNAs of EBV identified to reduce immune recognition further. This Gem summarizes what we know about immunomodulatory microRNAs of herpesviruses.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available